HRA Pharma Rare Diseases funds online hub for Cushing’s Syndrome
HRA Pharma Rare Diseases, an affiliate of global consumer healthcare company HRA Pharma, has announced it is funding an online platform containing information and news on Cushing’s Syndrome.
The ‘Cushing’s Hub’, developed by Springer Healthcare Education, is set to make all information on the rare condition available in one place for medical professionals to access.
Cushing’s Syndrome affects less than one in 10,000 people in the EU, and is categorised as a rare and severe condition caused by prolonged high levels of cortisol in the blood.
The new hub is managed by an independent editorial board consisting of three international Cushing’s Syndrome experts - Professor Frédéric Castinetti from France, Dr Niki Karavitaki from the UK and Associate Professor Dr Greisa Vila from Austria.
Read more:
http://www.pharmatimes.com/news/hra_pharma_rare_diseases_funds_online_hub_for_cushings_syndrome_1365376
The ‘Cushing’s Hub’, developed by Springer Healthcare Education, is set to make all information on the rare condition available in one place for medical professionals to access.
Cushing’s Syndrome affects less than one in 10,000 people in the EU, and is categorised as a rare and severe condition caused by prolonged high levels of cortisol in the blood.
The new hub is managed by an independent editorial board consisting of three international Cushing’s Syndrome experts - Professor Frédéric Castinetti from France, Dr Niki Karavitaki from the UK and Associate Professor Dr Greisa Vila from Austria.
Read more:
http://www.pharmatimes.com/news/hra_pharma_rare_diseases_funds_online_hub_for_cushings_syndrome_1365376
